Form C-U - Progress Update:
SEC Accession No. 0001665160-24-001345
Filing Date
2024-09-25
Accepted
2024-09-25 15:24:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C-U  
1 primary_doc.xml C-U 9620
  Complete submission text file 0001665160-24-001345.txt   10646
Mailing Address 1600 FAIRVIEW AVE E STE 300 SUITE 300 SEATTLE WA 98102
Business Address 1600 FAIRVIEW AVENUE EAST SUITE 300 SEATTLE WA 98102 2144788208
Deverra Therapeutics, Inc. (Filer) CIK: 0001822782 (see all company filings)

EIN.: 843312665 | State of Incorp.: DE
Type: C-U | Act: 33 | File No.: 020-33895 | Film No.: 241323399